Evidence map›Paper›PMID 26487685›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Regulation of DLK1 by the maternally expressed miR-379/miR-544 cluster may underlie callipyge polar overdominance inheritance.

Yun-Qian Gao, Xin Chen, Pei Wang, Lei Lu, Wei Zhao, Chen Chen, Cai-Ping Chen, Tao Tao, Jie Sun, Yan-Yan Zheng and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Molecular Mechanisms of Skeletal Muscle Hypertrophy.Journal of neuromuscular diseases · 2021
    Review
  9. Lack ofFrontiers in cell and developmental biology · 2021
    Article
  10. Article
  11. Deficiency and overexpression ofDevelopment (Cambridge, England) · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A Hearty Dose of Noncoding RNAs: The ImprintedJournal of cardiovascular development and disease · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Yun-Qian GaoState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Xin ChenState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Pei WangState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Lei LuState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Wei ZhaoState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Chen ChenState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Cai-Ping ChenState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Tao TaoState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Jie SunState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Yan-Yan ZhengState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Jie DuInnovation Center for Cardiovascular Disorders, Beijing Anzhen Hospital, Beijing 100029, China;
Chao-Jun LiState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Zhen-Ji GanState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Xiang GaoState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China;
Hua-Qun ChenSchool of Life Science, Nanjing Normal University, Nanjing 210009, China.
Min-Sheng ZhuState Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing 210061, China; Innovation Center for Cardiovascular Disorders, Beijing Anzhen Hospital, Beijing 100029, China; zhums@nju.edu.cn.
State Key Laboratory of Pharmaceutical BiotechnologyModel Animal Research Center · CNNanjing University · CNBeijing Anzhen Hospital · CNNanjing Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inheritance of the callipyge phenotype in sheep is an example of polar overdominance inheritance, an unusual mode of inheritance. To investigate the underlying molecular mechanism, we profiled the expression of the genes located in the Delta-like 1 homolog (Dlk1)-type III iodothyronine deiodinase (Dio3) imprinting region in mice. We found that the transcripts of the microRNA (miR) 379/miR-544 cluster were highly expressed in neonatal muscle and paralleled the expression of the Dlk1. We then determined the in vivo role of the miR-379/miR-544 cluster by establishing a mouse line in which the cluster was ablated. The maternal heterozygotes of young mutant mice displayed a hypertrophic tibialis anterior muscle, extensor digitorum longus muscle, gastrocnemius muscle, and gluteus maximus muscle and elevated expression of the DLK1 protein. Reduced expression of DLK1 was mediated by miR-329, a member of this cluster. Our results suggest that maternal expression of the imprinted miR-379/miR-544 cluster regulates paternal expression of the Dlk1 gene in mice. We therefore propose a miR-based molecular working model for polar overdominance inheritance.

Indexed as

Genomic ImprintingAnimalsCalcium-Binding ProteinsFemaleIntercellular Signaling Peptides and ProteinsMiceMicroRNAsMultigene FamilyCalcium-Binding ProteinsDlk1 protein, mouseIntercellular Signaling Peptides and ProteinsMicroRNAsMIRN379 microRNA, mouseMIRN-544 microRNA, mousecallipygeDLK1miR-379/miR-544 clustermuscle hypertrophy

Identifiers

PMID26487685
PMCPMC4640741
OpenAlexW1894466452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.